The price of Dupixent can vary based on factors such as insurance coverage, dosage, and geographic location. List prices for Dupixent are available, and patients often utilize patient assistance programs to help manage costs.
What is the typical cost of Dupixent?
The retail price for a 300 mg/2 mL vial of Dupixent can be around $3,700 to $4,000 for a 30-day supply [1]. Prices can fluctuate.
How do insurance plans affect Dupixent costs?
Insurance coverage significantly impacts out-of-pocket expenses for Dupixent. Many insurance plans require prior authorization and may have specific utilization management criteria. Co-pays can vary widely depending on the plan. Patients are advised to check their specific insurance formulary and benefits.
Are there programs to help with Dupixent costs?
Yes, Sanofi and Regeneron, the manufacturers of Dupixent, offer patient assistance programs. These programs, such as the Dupixent MyWay program, can provide co-pay coupons for eligible commercially insured patients, potentially lowering their monthly costs to as little as $5 [2][3]. For uninsured or underinsured patients, Dupixent MyWay may offer free medication through their Patient Assistance Program [2].
When does Dupixent's patent expire?
Information regarding Dupixent's patent expiration is available on specialized patent tracking websites [4]. Patent expiry dates are crucial for understanding when generic or biosimilar versions might become available, potentially influencing pricing.
What are the main uses for Dupixent?
Dupixent is a biologic medication approved for treating several moderate-to-severe inflammatory conditions. These include atopic dermatitis (eczema), asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), eosinophilic esophagitis (EoE), and prurigo nodularis [5].
How is Dupixent administered?
Dupixent is administered via subcutaneous injection. It is typically given every two weeks after an initial loading dose, though the dosing frequency can vary depending on the condition being treated [5].
Who manufactures Dupixent?
Dupixent is developed and marketed by Regeneron Pharmaceuticals and Sanofi Genzyme [6].